Antibiofilm and Antimicrobial Activity of Curcumin-chitosan Nanocomplexes and Trimethoprim-sulfamethoxazole on < em > Achromobacter, Burkholderia < /em > , and < em > Stenotrophomonas isolates < /em >
CONCLUSIONS: : Cur-Chi-TPP-MNP in combination with TMP-SXT was able to inhibit biofilm and in lower effect to eradicate established biofilms of clinical isolates of A. xylosoxidans, B. cepacia complex, and S. maltophilia species. Our results highlight the need to assess these potential treatment options to be used clinically in biofilm-associated infections.PMID:36625029 | DOI:10.1080/14787210.2023.2166933
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Authors: Edeer Iv án Montoya-Hinojosa Humberto Antonio Salazar-Sesatty Cynthia A Alvizo-Baez Luis D Terrazas-Armendariz Itza E Luna-Cruz Juan M Alcocer-Gonz ález Licet Villarreal-Trevi ño Samantha Flores-Trevi ño Source Type: research
More News: Bactrim | Burkholderia | Burkholderia Cepacia | Infectious Diseases | Nanotechnology | PET Scan | Sodium | Study | Sulfamethoxazole | Trimethoprim | Turmeric